Clinical Trial Update: Effect of Pioglitazone on T2DM Patients With COVID-19 [Phase 4]

View source ↗

Summary

Clinical trial evaluating the effect of pioglitazone in patients with type 2 diabetes and COVID-19 is in Phase 4; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Dasman Diabetes Institute | Conditions: Covid19, Type 2 Diabetes | Phase 4 | Status: UNKNOWN